Nephrology
Advertisement
The Filtrate rerecorded their episode on the PRAECIS trial regarding a blood test for preeclampsia due to listener feedback.
We had a great NephJC get together. We recorded the whole event and packaged it into a podcast.
Amino acid infusions to prevent AKI? It couldn’t be that simple, could it?
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
The American Society of Nephrology published the abstracts for Kidney Week 2024.
The American Nephrology Nurses Association (ANNA) has launched a fellowship program to honor outstanding nephrology nurses.
Listen to the second part of the discussion of Chapter 15 of Dr. Burton Rose's book, focused on diuretics.
The American Nephrology Nurses Association (ANNA) 2024 Nephrology Nursing Summit will take place September 16-18, 2024.
Interwell Health has more than 2000 nephrologists in its provider network, making it the largest in value-based kidney care.
It's time for another NephJC draft! This time the 2024 KDIGO CKD guideline draft is on the clock!
Kidney care provider Evergreen Nephrology has added David Young to its board of directors.
Susan Quaggin is the winner of the 2024 John P. Peters Award from the American Society of Nephrology.
The FDA has granted approval for ruxoprubart to begin phase 2 trials in patients with ANCA-associated vasculitis.
Kidney care providers can play a role in depression screening and help improve outcomes for patients with CKD.
Results of Nefecon (budesonide) for IgA nephropathy set the stage for a glomerulonephritis renaissance.
Vlado Perkovic presented results from the FLOW trial at the 61st ERA Congress, making headlines worldwide.
A blood test may help nephrologists answer the question, “Is this preeclampsia, proteinuric CKD, or a lupus flare?”
Transplant recipients often present with characteristics that may be associated with hyperkalemic renal tubular acidosis.
A study by Suphamai Bunnapradist and others found that dd-cfDNA is an early indicator of kidney transplant rejection.
Antinephrin autoantibodies can be a biomarker for the progression of kidney diseases associated with nephrotic syndrome.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.